# Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease

> **NCT00351286** · PHASE2 · UNKNOWN · sponsor: **Angiogenix** · enrollment: 160 (—)

## Conditions studied

- Peripheral Arterial Disease
- Intermittent Claudication

## Interventions

- **DRUG:** L-citrulline tablets, 1000 mg
- **DRUG:** Placebo tablets matching L-citrulline tablets
- **DRUG:** Background simvastatin at a stable dose of 40 mg qHS

## Key facts

- **NCT ID:** NCT00351286
- **Lead sponsor:** Angiogenix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 160 (—)
- **Last updated:** 2006-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351286, "Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00351286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*